Cronograma de promoção CanSino Biologics Inc.
Sobre a empresa
CanSino Biologics Inc. разрабатывает, производит и продает вакцины в Китайской Народной Республике. Компания разрабатывает Convidecia и Ad5-nCoV для ингаляционных вакцин против рекомбинантного нового коронавирусного заболевания; Ad5-EBOV, вакцина против вируса Эбола; и вакцины MCV2 и MCV4 для профилактики N. meningitides. Он также разрабатывает вакцину DTcP для младенцев и бустерную вакцину DTcP, которые проходят фазу I клинических испытаний для устранения более слабой защиты, предотвращающей коклюш после первичной вакцинации.
Mais detalhes| Выручка | 0.002 |
|---|---|
| EBITDA | -0.163 |
| P/E | 18.76 |
| P/S | 5743.25 |
| EV/EBITDA | -74.8 |
| Цена ао | 21.25 |
| P/BV | 8.92 |
| Дивиденд ао | 0.94 |
| Див.доход ао | 3.54 |
| Сайт | https://www.cansinotech.com |
| Число акций ао | 0.24745 млрд |
| Валюта | hkd |
| ISIN | CNE100003F01 |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Валюта отчета | cny |
| Alteração de preço por dia: | +3.41% (29.35) |
|---|---|
| Alteração de preço por semana: | -4.11% (31.65) |
| Alteração de preço por mês: | +22.13% (24.85) |
| Alteração de preço em 3 meses: | +73.23% (17.52) |
| Mudança de preço em seis meses: | +37.64% (22.05) |
| Mudança de preço por ano: | +11.58% (27.2) |
| Mudança de preço em 3 anos: | -80.95% (159.3) |
| Mudança de preço em 5 anos: | -9.54% (33.55) |
| Mudança de preço desde o início do ano: | +40.18% (21.65) |
|
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
|||||||||||||||||||||||||||||||||||||
| Instituições | Volume | Compartilhar, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 1298400 | 0.98 |
| Vanguard International Stock Index-Total Intl Stock Indx | 1197102 | 0.9 |
| New World Fund, Inc. | 832000 | 0.63 |
| iShares Core MSCI Emerging Markets ETF | 524000 | 0.39 |
| DFA Emerging Markets Core Equity Portfolio | 397600 | 0.3 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 141859 | 0.11 |
| Schwab Strategic Tr-Schwab Emerging Markets Equity ETF | 138467 | 0.1 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 105400 | 0.08 |
| College Retirement Equities Fund-Stock Account | 70200 | 0.05 |
| iShares MSCI China Small Cap ETF | 61600 | 0.05 |
| ETF | Compartilhar, % | Rentabilidade para o ano, % | Dividendos, % |
|---|---|---|---|
| SPDR S&P Emerging Markets Small Cap ETF | 0.02973 | 9.4592150479291 | 3.03583 |
| Franklin FTSE China ETF | 0.01331 | 14.495305164319 | 3.35323 |
| SPDR S&P China ETF | 0.00597 | 5.8641975308642 | 3.40103 |
| SPDR Portfolio Emerging Markets ETF | 0.00091 | 13.575967648758 | 3.1879 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.00079 | 12.462475271255 | 3.59676 |
| Vanguard ESG International Stock ETF | 0 | 10.20253643763 | 3.07501 |
| Direxion Daily Japan Bull 3x Shares | 0.00035 | 6.34 | 2.48436 |
| Supervisor | Cargo | Pagamento | Ano de nascimento |
|---|---|---|---|
| Dr. Xuefeng Yu Ph.D. | Co-Founder, Executive Chairman, CEO & GM | N/A | 1965 (59 anos) |
| Dr. Tao Zhu Ph.D. | Co-Founder, Deputy GM & Chief Scientific Officer | N/A | 1973 (51 ano) |
| Dr. Dongxu Qiu MBA, Ph.D. | Co-Founder, Executive VP & Deputy GM | N/A | 1960 (64 ano) |
| Mr. Chunlin Xin | Senior Director of New Technology Department | N/A | |
| Mr. Yonghui Wu | Vice President of Marketing | N/A | |
| Ms. Jing Wang | Chief Commercial Officer, Deputy GM & Executive Director | N/A | 1981 (43 ano) |
| Mr. Ming King Chiu FCIS, FCS | Joint Company Secretary | N/A | 1977 (47 anos) |
| Mr. Jin Cui | Board Secretary | N/A | 1987 (37 anos) |
| Dr. Shou-Bai Chao Ph.D. | COO, Deputy GM & Executive Director | N/A | 1964 (60 anos) |
Endereço: China, Tianjin, 401-420 Biomedical Park - abrir no Google Maps, abrir mapas Yandex
Site: https://www.cansinotech.com
Site: https://www.cansinotech.com
